Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban.
作者信息
Messori Andrea, Maratea Dario, Fadda Valeria, Trippoli Sabrina
机构信息
Health Technology Assessment Unit, ESTAV Toscana Centro, Regional Health Service, 50100, Firenze, Italy,
出版信息
Eur J Clin Pharmacol. 2014 Apr;70(4):505-6. doi: 10.1007/s00228-014-1644-7. Epub 2014 Jan 23.
PMID:24452835
Abstract
摘要
Zotero 插件